Moderna inventory slides 11.5% premarket after earnings miss by a large margin and firm cuts gross sales outlook by as much as $3 billion
[ad_1] Moderna Inc. shares plunged 11% in premarket commerce Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings
Read More